Huayi Isotopes, a subsidiary of Huayi Technology Co., Ltd., has received a Drug Master File (DMF) acceptance letter from the U.S. Food and Drug Administration (FDA) for its DOTATATE ACETATE (DMF No. 041558), a peptide-based precursor for radiopharmaceuticals. ...
Huayi Pharmaceutical (Guangdong) Co., Ltd. successfully obtained the “Radioactive Pharmaceutical Production License” issued by the National Medical Products Administration. ...
We proudly announces a significant milestone with the successful acquisition of Drug Master File (DMF) registration for the PSMA-11 precursor. This achievement underscores Huayi's unwavering commitment to upholding the highest standards in the development and production of radiopharmaceuticals....
The 63rd Annual Meeting of the Japanese Society of Nuclear Medicine (JSNM) and the 43rd Annual Meeting of the Japanese Society of Nuclear Medicine Technology (JSNMT) took place in Osaka from November 16th to 18th, attracting experts from around the world. ...
Jiangsu Huayi Technology Co., Ltd. (Huayi) Shines Bright at the 2023 WMIC and EANM Annual Conference....
Recently, Prof. Opa Vajragupta and Prof. Pornchai Rojsitthisak of Chulalongkorn University and Prof. Kittisak Sripha and Prof. Satsawat Visansirikul of Mahidol University visited our company, Jiangsu Huayi Technology Co., Ltd. (Huayi). Roujian Lu, Vice President of the company and General Manager of Huayi Isotopes Co., a division of Jiangsu Huayi Technology Co., Ltd. warmly welcomed the guests from Thailand with his co-workers....
We supply the precursors for normal GMP production, as well as some research compounds for new tracers. HIC provides custom synthesis services to academic and government institutions under strict confidence.We supply the precursors for normal GMP production, as well as some research compounds for new tracers. HIC provides custom synthesis services to academic and government institutions under strict confidence....
As the COVID-19 continues to affect the world and the challenges of radiopharmaceutical development and innovation become more prominent, we are more eager to innovate breakthroughs and seek global partners to enhance our insights and business capabilities....